Rising to the Challenge

Rising to the Challenge

National Jewish Health has always approached the most difficult illnesses through science, education and comprehensive care to find solutions and improve lives. The highlights below show how we rose to the challenges of 2020.

My Life My Quit™, teen nicotine cessation program was offered in 19 states, enrolled 1,287 teens and had more than 1.6 million website pageviews.

Scleroderma, Sarcoidosis and Pulmonary Hypertension programs recognized for clinical and research excellence November 2020 National Jewish Health began construction of Center for Outpatient Health.

European Academy of Allergy and Clinical Immunology name Donald Leung, MD, a “Legend of Allergy and Immunology.”

Jennifer Taylor-Cousar, MD reports a triple combination therapy that helps 90 percent of cystic fibrosis patients.

Kevin Brown, MD, named Chair of Department of Medicine.

National Jewish Health launches one of the first COVID-19 public health information websites.

National Jewish Health experts informed the public about COVID-19 through hundreds of local and national media interviews.

National Jewish Health was first Colorado hospital to offer molecular diagnostic testing.

Critical Care and ICU physicians manage care in Denver and across 25 western states.

60+ grants submitted regarding COVID-19 research projects.

Mass COVID-19 testing available from National Jewish Health at many Denver locations and for other states.